ClinConnect ClinConnect Logo
Search / Trial NCT06878716

Silver Russell Syndrome, Parental Fertility and Assisted Reproductive Technology

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Mar 10, 2025

Trial Information

Current as of April 29, 2025

Not yet recruiting

Keywords

Imprinting Disorders Silver Russell Syndrome Infertility Assisted Reproductive Technology In Vitro Fertilization

ClinConnect Summary

This clinical trial is studying Silver Russell Syndrome (SRS), a rare genetic condition that affects how certain genes are expressed. Researchers want to understand how often parents of children with SRS have used assisted reproductive technology (ART), such as in vitro fertilization (IVF), to conceive. They are also interested in the infertility rates among these parents, the possible causes of infertility, and the specific ART methods used. By gathering this information, the study aims to shed light on the connection between ART and the occurrence of SRS.

If you are a parent of a child diagnosed with SRS and are over 18 years old, you may be eligible to participate in this study. Participation involves answering questions about your fertility and the methods used to conceive your child, which will be done through a phone interview. If ART was used, additional details about the techniques will be gathered from your doctor. Your answers will be kept private and will help researchers better understand SRS and its relationship with assisted reproductive methods.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ≥ 18 years old
  • parents from patients followed in the department " Unité Fonctionnelle Endocrinienne du Pr Netchine " for un Silver Russell syndrome
  • Exclusion Criteria:
  • parent's objection
  • patient under State Medical Aid

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, , France

Patients applied

0 patients applied

Trial Officials

Irène Netchine, PUPH, MD, PhD

Principal Investigator

Assistance Publique - Hôpitaux de Paris

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported